The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 04, 2026
Filed:
Nov. 30, 2023
Applicant:
Cornell University, Ithaca, NY (US);
Inventors:
Ethel Cesarman, Jersey City, NJ (US);
Utthara Nayar, Boston, MA (US);
J. David Warren, New York, NY (US);
Jouliana Sadek, Roosevelt Island, NY (US);
Assignee:
CORNELL UNIVERSITY, Ithaca, NY (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7076 (2006.01); A61P 35/00 (2006.01); C07H 19/16 (2006.01); C07H 19/167 (2006.01); C07H 19/20 (2006.01); C07H 19/213 (2006.01); C12Q 1/6886 (2018.01); G01N 33/50 (2006.01); G01N 33/575 (2026.01);
U.S. Cl.
CPC ...
C07H 19/16 (2013.01); A61K 31/7076 (2013.01); A61P 35/00 (2018.01); C07H 19/167 (2013.01); C07H 19/20 (2013.01); C07H 19/213 (2013.01); C12Q 1/6886 (2013.01); G01N 33/5011 (2013.01); G01N 33/575 (2026.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/912 (2013.01);
Abstract
The present disclosure is directed to novel nucleoside analog compounds and methods for treating diseases characterized by high expression levels of adenosine kinase (ADK).
Cesarman, Ethel. (2026). Nucleoside analogs and use thereof in therapeutic treatment (U.S. Patent No. 12698305). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12698305
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile